{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:07:10Z","timestamp":1773662830409,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Neurological Foundation of N.Z."},{"DOI":"10.13039\/501100001511","name":"Auckland Medical Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001511","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute grants","doi-asserted-by":"crossref","award":["RF07.96 M"],"award-info":[{"award-number":["RF07.96 M"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute grants","doi-asserted-by":"crossref","award":["RF08.32"],"award-info":[{"award-number":["RF08.32"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["DA009789"],"award-info":[{"award-number":["DA009789"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.neuropharm.2013.12.007","type":"journal-article","created":{"date-parts":[[2013,12,13]],"date-time":"2013-12-13T01:23:03Z","timestamp":1386897783000},"page":"467-475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta"],"prefix":"10.1016","volume":"79","author":[{"given":"Peter S.","family":"Freestone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezia","family":"Guatteo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Piscitelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"di Marzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz","family":"Lipski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola B.","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neuropharm.2013.12.007_bib1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1124\/mol.109.057356","article-title":"Dual role of the second extracellular loop of the cannabinoid receptor 1: ligand binding and receptor localization","volume":"76","author":"Ahn","year":"2009","journal-title":"Mol. Pharmacol."},{"issue":"8","key":"10.1016\/j.neuropharm.2013.12.007_bib2","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0028-3908(01)00145-9","article-title":"The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice","volume":"41","author":"Al-Hayani","year":"2001","journal-title":"Neuropharmacology"},{"issue":"7006","key":"10.1016\/j.neuropharm.2013.12.007_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nature02913","article-title":"Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids","volume":"431","author":"Bacci","year":"2004","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.neuropharm.2013.12.007_bib4","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1046\/j.1460-9568.1999.00627.x","article-title":"Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms","volume":"11","author":"Bezard","year":"1999","journal-title":"Eur. J. Neurosci."},{"issue":"Pt 3","key":"10.1016\/j.neuropharm.2013.12.007_bib5","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1042\/bj3510817","article-title":"N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in\u00a0vitro and in\u00a0vivo","volume":"351","author":"Bisogno","year":"2000","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.neuropharm.2013.12.007_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ejlt.200800233","article-title":"Lipidomic methodologies applicable to the study of endocannabinoids and related compounds: Endocannabinoidomics","volume":"111","author":"Bisogno","year":"2009","journal-title":"Eur. J. Lipid Sci. Technol."},{"issue":"11","key":"10.1016\/j.neuropharm.2013.12.007_bib7","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/j.1460-9568.1997.tb01653.x","article-title":"Glutamate metabotropic receptor agonists depress excitatory and inhibitory transmission on rat mesencephalic principal neurons","volume":"9","author":"Bonci","year":"1997","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2013.12.007_bib8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1471-4892(02)00011-5","article-title":"CB1 cannabinoid receptor signalling in Parkinson's disease","volume":"3","author":"Brotchie","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"issue":"11","key":"10.1016\/j.neuropharm.2013.12.007_bib9","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S1474-4422(10)70218-0","article-title":"Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap","volume":"9","author":"Calabresi","year":"2010","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.neuropharm.2013.12.007_bib10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.expneurol.2009.09.027","article-title":"Glutamate, excitotoxicity, and programmed cell death in Parkinson disease","volume":"220","author":"Caudle","year":"2009","journal-title":"Exp Neurol"},{"issue":"4","key":"10.1016\/j.neuropharm.2013.12.007_bib11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1523\/JNEUROSCI.4152-06.2007","article-title":"Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation","volume":"27","author":"Cheer","year":"2007","journal-title":"J.\u00a0Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2013.12.007_bib12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1471-4159.2002.00811.x","article-title":"Synaptic regulation of somatodendritic dopamine release by glutamate and GABA differs between substantia nigra and ventral tegmental area","volume":"81","author":"Chen","year":"2002","journal-title":"J.\u00a0Neurochem."},{"issue":"2","key":"10.1016\/j.neuropharm.2013.12.007_bib13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0022-3565(25)12911-X","article-title":"In\u00a0vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity","volume":"277","author":"Compton","year":"1996","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"5090","key":"10.1016\/j.neuropharm.2013.12.007_bib14","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.neuropharm.2013.12.007_bib15","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1523\/JNEUROSCI.4876-07.2008","article-title":"Glutamate spillover modulates GABAergic synaptic transmission in the rat midbrain periaqueductal grey via metabotropic glutamate receptors and endocannabinoid signaling","volume":"28","author":"Drew","year":"2008","journal-title":"J.\u00a0Neurosci."},{"issue":"10","key":"10.1016\/j.neuropharm.2013.12.007_bib16","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/mds.21475","article-title":"Levodopa-induced dyskinesias","volume":"22","author":"Fabbrini","year":"2007","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.neuropharm.2013.12.007_bib17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1124\/jpet.104.078980","article-title":"Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3\u2032-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation","volume":"313","author":"Fegley","year":"2005","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.neuropharm.2013.12.007_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-3565(24)37189-7","article-title":"LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation","volume":"284","author":"Felder","year":"1998","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.neuropharm.2013.12.007_bib19","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/j.1755-5949.2010.00144.x","article-title":"Cannabinoid\u2013dopamine interaction in the pathophysiology and treatment of CNS disorders","volume":"16","author":"Fern\u00e1ndez-Ruiz","year":"2010","journal-title":"CNS Neurosci. Ther."},{"issue":"7","key":"10.1016\/j.neuropharm.2013.12.007_bib20","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1476-5381.2011.01365.x","article-title":"Prospects for cannabinoid therapies in basal ganglia disorders","volume":"163","author":"Fern\u00e1ndez-Ruiz","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.neuropharm.2013.12.007_bib21","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1460-9568.2009.06990.x","article-title":"Acute action of rotenone on nigral dopaminergic neurons \u2013 involvement of reactive oxygen species and disruption of Ca2+ homeostasis","volume":"30","author":"Freestone","year":"2009","journal-title":"Eur. J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2013.12.007_bib22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00001756-199702100-00014","article-title":"Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra","volume":"8","author":"French","year":"1997","journal-title":"Neuroreport"},{"issue":"0","key":"10.1016\/j.neuropharm.2013.12.007_bib23","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.expneurol.2013.02.009","article-title":"Dual effects of L-DOPA on nigral dopaminergic neurons","volume":"247","author":"Guatteo","year":"2013","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.neuropharm.2013.12.007_bib24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neulet.2009.01.061","article-title":"Functional type I vanilloid receptor expression by substantia gelatinosa neurons of trigeminal subnucleus caudalis in mice","volume":"452","author":"Han","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"42","key":"10.1016\/j.neuropharm.2013.12.007_bib25","doi-asserted-by":"crossref","first-page":"9746","DOI":"10.1523\/JNEUROSCI.2769-05.2005","article-title":"Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids","volume":"25","author":"Hentges","year":"2005","journal-title":"J.\u00a0Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2013.12.007_bib26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.plefa.2009.05.026","article-title":"The biosynthesis of N-arachidonoyl dopamine (NADA), a putative endocannabinoid and endovanilloid, via conjugation of arachidonic acid with dopamine","volume":"81","author":"Hu","year":"2009","journal-title":"Prostag. Leukotr. Essential Fatty Acids"},{"issue":"12","key":"10.1016\/j.neuropharm.2013.12.007_bib27","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1073\/pnas.122196999","article-title":"An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors","volume":"99","author":"Huang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.neuropharm.2013.12.007_bib28","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1523\/JNEUROSCI.21-06-01838.2001","article-title":"Differential subcellular localization of mGluR1a and mGluR5 in the rat and monkey Substantia Nigra","volume":"21","author":"Hubert","year":"2001","journal-title":"J.\u00a0Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2013.12.007_bib29","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.neuroscience.2009.11.054","article-title":"Endocannabinoids contribute to metabotropic glutamate receptor-mediated inhibition of GABA release onto hippocampal CA3 pyramidal neurons in an isolated neuron\/bouton preparation","volume":"165","author":"Inada","year":"2010","journal-title":"Neuroscience"},{"issue":"15","key":"10.1016\/j.neuropharm.2013.12.007_bib30","doi-asserted-by":"crossref","first-page":"8733","DOI":"10.1073\/pnas.96.15.8733","article-title":"Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin","volume":"96","author":"Jabaudon","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2013.12.007_bib31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.neuropharm.2013.12.007_bib32","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nn.2517","article-title":"Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses","volume":"13","author":"Kim","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"23","key":"10.1016\/j.neuropharm.2013.12.007_bib33","doi-asserted-by":"crossref","first-page":"10182","DOI":"10.1523\/JNEUROSCI.22-23-10182.2002","article-title":"Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus","volume":"22","author":"Kim","year":"2002","journal-title":"J.\u00a0Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2013.12.007_bib34","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0306-4522(97)00654-4","article-title":"Expression of metabotropic glutamate receptor 1 isoforms in the substantia nigra pars compacta of the rat","volume":"86","author":"Kosinski","year":"1998","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.neuropharm.2013.12.007_bib35","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0896-6273(01)00246-X","article-title":"Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells","volume":"29","author":"Kreitzer","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2013.12.007_bib36","first-page":"71","volume":"vol. 73","author":"Lee","year":"2009"},{"issue":"9","key":"10.1016\/j.neuropharm.2013.12.007_bib37","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.bcp.2008.08.006","article-title":"Paraquat inhibits postsynaptic AMPA receptors on dopaminergic neurons in the substantia nigra pars compacta","volume":"76","author":"Lee","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2013.12.007_bib38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1042\/bj2980213","article-title":"Partial purification of a diacylglycerol lipase from bovine aorta","volume":"298","author":"Lee","year":"1994","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.neuropharm.2013.12.007_bib39","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1073\/pnas.0304752101","article-title":"Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons","volume":"101","author":"Losonczy","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2013.12.007_bib40","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0896-6273(01)00375-0","article-title":"Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors","volume":"31","author":"Maejima","year":"2001","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.neuropharm.2013.12.007_bib41","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.npp.1301118","article-title":"N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors","volume":"32","author":"Marinelli","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"50","key":"10.1016\/j.neuropharm.2013.12.007_bib42","doi-asserted-by":"crossref","first-page":"13532","DOI":"10.1523\/JNEUROSCI.0847-08.2008","article-title":"The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self-inhibition in neocortical interneurons","volume":"28","author":"Marinelli","year":"2008","journal-title":"J.\u00a0Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2013.12.007_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-2999(02)01575-3","article-title":"Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain","volume":"443","author":"Mato","year":"2002","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2013.12.007_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2013.12.007_bib45","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/(SICI)1098-2396(199706)26:2<184::AID-SYN9>3.0.CO;2-4","article-title":"Metabotropic glutamate receptor-mediated inhibition and excitation of substantia nigra dopamine neurons","volume":"26","author":"Meltzer","year":"1997","journal-title":"Synapse"},{"issue":"Suppl.\u00a00","key":"10.1016\/j.neuropharm.2013.12.007_bib46","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0197-0186(92)90240-R","article-title":"Actions of Levodopa on rat substantia nigra zona compacta neurons","volume":"20","author":"Mercuri","year":"1992","journal-title":"Neurochem. Int."},{"issue":"0","key":"10.1016\/j.neuropharm.2013.12.007_bib47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuroscience.2011.08.023","article-title":"Dynamic regulation of midbrain dopamine neuron activity: intrinsic, synaptic, and plasticity mechanisms","volume":"198","author":"Morikawa","year":"2011","journal-title":"Neuroscience"},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2013.12.007_bib48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1113\/jphysiol.2006.115691","article-title":"Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus","volume":"578","author":"Neu","year":"2007","journal-title":"J.\u00a0Physiol."},{"issue":"3","key":"10.1016\/j.neuropharm.2013.12.007_bib49","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0896-6273(01)00247-1","article-title":"Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals","volume":"29","author":"Ohno-Shosaku","year":"2001","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.neuropharm.2013.12.007_bib50","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1523\/JNEUROSCI.2676-06.2007","article-title":"Retrograde regulation of GABA transmission by the tonic release of oxytocin and endocannabinoids governs postsynaptic firing","volume":"27","author":"Oliet","year":"2007","journal-title":"J.\u00a0Neurosci."},{"issue":"21","key":"10.1016\/j.neuropharm.2013.12.007_bib51","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1021\/jm800978m","article-title":"Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism","volume":"51","author":"Ortar","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"issue":"4","key":"10.1016\/j.neuropharm.2013.12.007_bib52","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neurobiolaging.2009.03.017","article-title":"Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors","volume":"32","author":"P\u00e9rez-Rial","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"12","key":"10.1016\/j.neuropharm.2013.12.007_bib53","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1046\/j.1460-9568.2002.02041.x","article-title":"Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids","volume":"15","author":"Szabo","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.12.007_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0079-6123(06)60001-0","article-title":"Basal ganglia macrocircuits","volume":"160","author":"Tepper","year":"2007","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2013.12.007_bib55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0079-6123(06)60011-3","article-title":"GABAergic control of substantia nigra dopaminergic neurons","volume":"160","author":"Tepper","year":"2007","journal-title":"Prog. Brain Res."},{"issue":"6","key":"10.1016\/j.neuropharm.2013.12.007_bib56","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1152\/jn.2001.85.6.2490","article-title":"Group I mGluRs coupled to G proteins are regulated by tyrosine kinase in dopamine neurons of the rat midbrain","volume":"85","author":"Tozzi","year":"2001","journal-title":"J.\u00a0Neurophysiol."},{"issue":"3","key":"10.1016\/j.neuropharm.2013.12.007_bib57","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.neuroscience.2010.05.036","article-title":"Endocannabinoid-mediated synaptically evoked suppression of GABAergic transmission in the cerebellar cortex","volume":"169","author":"Urbanski","year":"2010","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.neuropharm.2013.12.007_bib58","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1096\/fj.04-3010fje","article-title":"A\u00a0role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease","volume":"19","author":"van der Stelt","year":"2005","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.neuropharm.2013.12.007_bib59","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0306-4522(02)00109-4","article-title":"Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse","volume":"113","author":"Wallmichrath","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.12.007_bib60","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.brainres.2010.09.086","article-title":"The effects of cannabinoid drugs on abnormal involuntary movements in dyskinetic and non-dyskinetic 6-hydroxydopamine lesioned rats","volume":"1363","author":"Walsh","year":"2010","journal-title":"Brain Res."},{"issue":"0","key":"10.1016\/j.neuropharm.2013.12.007_bib61","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neuroscience.2011.06.048","article-title":"Pathological basal ganglia activity in movement disorders","volume":"198","author":"Wichmann","year":"2011","journal-title":"Neuroscience"},{"issue":"6828","key":"10.1016\/j.neuropharm.2013.12.007_bib62","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/35069076","article-title":"Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses","volume":"410","author":"Wilson","year":"2001","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neuropharm.2013.12.007_bib63","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0306-4522(03)00607-9","article-title":"Retrograde signaling changes the venue of postsynaptic inhibition in rat substantia nigra","volume":"122","author":"Yanovsky","year":"2003","journal-title":"Neuroscience"},{"issue":"20","key":"10.1016\/j.neuropharm.2013.12.007_bib64","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1113\/jphysiol.2011.212225","article-title":"Postsynaptic diacylglycerol lipase \u03b1 mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex","volume":"589","author":"Yoshino","year":"2011","journal-title":"J.\u00a0Physiol."},{"issue":"33","key":"10.1016\/j.neuropharm.2013.12.007_bib65","doi-asserted-by":"crossref","first-page":"10585","DOI":"10.1523\/JNEUROSCI.23-33-10585.2003","article-title":"Glutamate spillover in the striatum depresses dopaminergic transmission by activating group I metabotropic glutamate receptors","volume":"23","author":"Zhang","year":"2003","journal-title":"J.\u00a0Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2013.12.007_bib66","doi-asserted-by":"crossref","first-page":"e16305","DOI":"10.1371\/journal.pone.0016305","article-title":"Endocannabinoids generated by Ca2+ or by metabotropic glutamate receptors appear to arise from different pools of diacylglycerol lipase","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS ONE"},{"issue":"26","key":"10.1016\/j.neuropharm.2013.12.007_bib67","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1523\/JNEUROSCI.1148-05.2005","article-title":"Retrograde endocannabinoid signaling in a postsynaptic Neuron\/Synaptic bouton preparation from Basolateral Amygdala","volume":"25","author":"Zhu","year":"2005","journal-title":"J.\u00a0Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813005790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813005790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T04:42:10Z","timestamp":1746074530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390813005790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":67,"alternative-id":["S0028390813005790"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.12.007","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}